Kyowa Kirin

Kyowa Kirin Continues Commitment to Making Dreams Possible

by

Global specialty pharmaceutical company supports Dream Foundation’s work to provide comfort, closure, and inspiration at the end of life. BEDMINSTER, N.J. and SANTA BARBARA, Calif., May 30, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin. Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, has extended its support of Dream Foundation – … Read more

Kyowa Kirin Presents New Findings from Real-World Study in Parkinson’s Disease at the 2023 IAPRD Conference

by

Findings to be presented at International Association of Parkinsonism and Related Disorders (IARPD) 2023 World Congress being held May 13-16, 2023. BEDMINSTER, N.J., May 12, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, will share results from a retrospective study evaluating … Read more